Press release
Arthralgia Market: Accelerating Growth and Pipeline Impact - DelveInsight | Sun Pharma, Bristol-Myers Squibb, UCB Biopharma, Affibody AB, Ventyx Biosciences, Aclaris Therapeutics, AbbVie, Novartis
DelveInsight's "Arthralgia Market Insights, Epidemiology, and Market Forecast-2032 report offers an in-depth understanding of the Arthralgia, historical and forecasted epidemiology as well as the Arthralgia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
Get a Free sample for the Arthralgia Market Report:
https://www.delveinsight.com/report-store/arthralgia-market [https://www.delveinsight.com/report-store/arthralgia-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Some of the key facts of the Arthralgia Market Report:
*
The Arthralgia market size is estimated to grow with a significant CAGR during the study period (2019-2032).
*
In September 2025, SI-BONE Inc. announced the launch of a prospective, multicenter clinical study assessing sacroiliac joint (SIJ) fusion with the iFuse TORQ implant system. The study's primary aim is to establish the device's safety and clinical effectiveness for its intended use.
*
In September 2022, The United States Food and Drug Administration (USFDA) granted approval to Deucravacitinib, an oral, selective tyrosine kinase 2 (TYK2) inhibitor, for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. This approval represents a significant milestone for the Arthralgia therapeutics market, as Deucravacitinib has the potential to become a new option for patients suffering from this condition.
*
Arthralgia affected women more than it did men, according to DelveInsight's data. For example, in Japan in 2021, there were about 34,000 cases of Arthralgia in males and about 39,000 in females.
*
Key Arthralgia Companies: Sun Pharma, Bristol-Myers Squibb, UCB Biopharma, Affibody AB, Sun Pharmaceutical Industries, Ventyx Biosciences, Aclaris Therapeutics, AbbVie, Novartis, Janssen Research & Development, LLC, MoonLake Immunotherapeutics AG, and others
*
Key Arthralgia Therapies: ILUMYA, Deucravacitinib, Bimekizumab, Izokibep, SUNPG18_07, VTX958, ATI-450, Risankizumab, Upadacitinib, AIN457, Ustekinumab, Sonelokimab and others
*
The Arthralgia epidemiology based on gender analyzed that the prevalence of moderate cases is the highest, followed by severe and mild cases
*
The Arthralgia market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Arthralgia pipeline products will significantly revolutionize the Arthralgia market dynamics.
Arthralgia Overview
Arthralgia is a medical term used to describe pain or discomfort in one or more joints. Joints are the connections between bones, and arthralgia can affect various parts of the body, such as the knees, elbows, wrists, or shoulders. The pain associated with arthralgia can be caused by inflammation, injury, infection, or other underlying conditions affecting the joints.
To Know in detail about the Arthralgia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Arthralgia Market Forecast [https://www.delveinsight.com/sample-request/arthralgia-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Arthralgia Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Arthralgia Epidemiology Segmentation:
The Arthralgia market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
*
Total Prevalence of Arthralgia
*
Prevalent Cases of Arthralgia by severity
*
Gender-specific Prevalence of Arthralgia
*
Diagnosed Cases of Episodic and Chronic Arthralgia
Download the report to understand which factors are driving Arthralgia epidemiology trends @ Arthralgia Epidemiology Forecast [https://www.delveinsight.com/sample-request/arthralgia-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Arthralgia Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Arthralgia market or expected to get launched during the study period. The analysis covers Arthralgia market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Arthralgia Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Arthralgia Therapies and Key Companies
*
ILUMYA: Sun Pharma
*
Deucravacitinib: Bristol-Myers Squibb
*
Bimekizumab: UCB Biopharma
*
Izokibep: Affibody AB
*
SUNPG18_07: Sun Pharmaceutical Industries Limited
*
VTX958: Ventyx Biosciences, Inc
*
ATI-450: Aclaris Therapeutics, Inc.
*
Risankizumab: AbbVie
*
Upadacitinib: AbbVie
*
AIN457: Novartis
*
Ustekinumab: Janssen Research & Development, LLC
*
Sonelokimab: MoonLake Immunotherapeutics AG
Discover more about therapies set to grab major Arthralgia market share @ Arthralgia Treatment Market [https://www.delveinsight.com/sample-request/arthralgia-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Arthralgia Market Drivers
*
Rising prevalence of musculoskeletal disorders, arthritis, and age-related joint pain worldwide
*
Growing geriatric population increasing demand for long-term pain management therapies
*
Increased awareness and diagnosis of joint pain associated with autoimmune and inflammatory conditions
*
Advancements in analgesics, anti-inflammatory drugs, and non-opioid pain management options
*
Expanding use of combination therapies, physical rehabilitation, and supportive care approaches
Arthralgia Market Barriers
*
Lack of disease-specific therapies, as arthralgia is a symptom rather than a standalone disease
*
Safety concerns related to long-term use of NSAIDs, opioids, and corticosteroids
*
Variable treatment response due to diverse underlying causes of joint pain
*
Limited reimbursement for symptomatic treatments in certain healthcare systems
*
Availability of low-cost generics and non-pharmacological alternatives creating pricing pressure
Scope of the Arthralgia Market Report
*
Study Period: 2019-2032
*
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
*
Key Arthralgia Companies: Sun Pharma, Bristol-Myers Squibb, UCB Biopharma, Affibody AB, Sun Pharmaceutical Industries, Ventyx Biosciences, Aclaris Therapeutics, AbbVie, Novartis, Janssen Research & Development, LLC, MoonLake Immunotherapeutics AG, and others
*
Key Arthralgia Therapies: ILUMYA, Deucravacitinib, Bimekizumab, Izokibep, SUNPG18_07, VTX958, ATI-450, Risankizumab, Upadacitinib, AIN457, Ustekinumab, Sonelokimab, and others
*
Arthralgia Therapeutic Assessment: Arthralgia current marketed and Arthralgia emerging therapies
*
Arthralgia Market Dynamics: Arthralgia market drivers and Arthralgia market barriers
*
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
*
Arthralgia Unmet Needs, KOL's views, Analyst's views, Arthralgia Market Access and Reimbursement
To know more about Arthralgia companies working in the treatment market, visit @ Arthralgia Clinical Trials and Therapeutic Assessment [https://www.delveinsight.com/sample-request/arthralgia-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Table of Contents
1. Arthralgia Market Report Introduction
2. Executive Summary for Arthralgia
3. SWOT analysis of Arthralgia
4. Arthralgia Patient Share (%) Overview at a Glance
5. Arthralgia Market Overview at a Glance
6. Arthralgia Disease Background and Overview
7. Arthralgia Epidemiology and Patient Population
8. Country-Specific Patient Population of Arthralgia
9. Arthralgia Current Treatment and Medical Practices
10. Arthralgia Unmet Needs
11. Arthralgia Emerging Therapies
12. Arthralgia Market Outlook
13. Country-Wise Arthralgia Market Analysis (2019-2032)
14. Arthralgia Market Access and Reimbursement of Therapies
15. Arthralgia Market Drivers
16. Arthralgia Market Barriers
17. Arthralgia Appendix
18. Arthralgia Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=arthralgia-market-accelerating-growth-and-pipeline-impact-delveinsight-sun-pharma-bristolmyers-squibb-ucb-biopharma-affibody-ab-ventyx-biosciences-aclaris-therapeutics-abbvie-novartis]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Arthralgia Market: Accelerating Growth and Pipeline Impact - DelveInsight | Sun Pharma, Bristol-Myers Squibb, UCB Biopharma, Affibody AB, Ventyx Biosciences, Aclaris Therapeutics, AbbVie, Novartis here
News-ID: 4384805 • Views: …
More Releases from ABNewswire
Whisk Laundry Service Expands Professional Wash and Fold and Commercial Laundry …
Whisk Laundry Service continues to grow its pickup and delivery laundry services, offering streamlined wash and fold and commercial laundry services designed for busy households and businesses throughout the United States.
United States - February 10, 2026 - Whisk Laundry Service [https://whisklaundry.com], a provider of scheduled pickup and delivery laundry services, continues expanding its operations to meet growing demand for reliable wash and fold and commercial laundry solutions across the United…
College Speaker Marc Reede, author of the Mel Robbins-endorsed book "The Coffee …
College to Career Transition author and college speaker Marc Reede has received high-profile praise from Global podcaster/author Mel Robbins for his book The Coffee Code, calling it "a career playbook... jam-packed with real-world wisdom." Designed to help students and early-career professionals navigate the transition from college to the workplace, The Coffee Code offers practical guidance on networking, mentorship, and professional confidence-skills essential for early career success.
LOS ANGELES, CA - February…
Severe Asthma Market: High-Growth Opportunities for Investors to 2034 - DelveIns …
The Key Severe Asthma Companies in the market include - Teva Pharmaceutical, AstraZeneca, Upstream Bio Inc., Oneness Biotech Co., Chia Tai Tianqing Pharmaceutical, Nantes University Hospital, Hamad Medical Corporation, Incyte Corporation, CSPC ZhongQi Pharmaceutical, AstraZeneca, Sunshine Guojian Pharmaceutical, Amgen, Areteia Therapeutics, Sanofi, GlaxoSmithKline, EMS, Advagene Biopharma Co., Teva Branded Pharmaceutical, and others.
DelveInsight's "Severe Asthma Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Severe Asthma, historical…
2026 Cervical Pillow Market Report: Independent Analysis Reveals Top 5 Solutions …
New market research identifies emerging brands disrupting the $4.2 billion orthopedic pillow industry. The report names CozyRest by The Pillow Home as the "Best Overall Value," outperforming legacy brands in clinical efficacy and ergonomic design.
NEW YORK, NY - February 10, 2026 - A comprehensive market analysis conducted by sleep health researchers has identified significant shifts in the cervical pillow industry, with emerging brands challenging established players through superior clinical design…
More Releases for Arthralgia
Arthralgia Market Growth, Applications, Innovations and Business Outlook by 2034
Introduction
Arthralgia, or joint pain, is a common clinical symptom associated with a wide range of conditions, including osteoarthritis, rheumatoid arthritis, lupus, infections, and injury-related disorders. While not a disease itself, arthralgia significantly impacts patient quality of life and is one of the leading reasons for clinical visits globally.
Download Full PDF Sample Copy of Market Report @https://exactitudeconsultancy.com/request-sample/71333
Historically managed with analgesics, NSAIDs, and corticosteroids, the treatment landscape is evolving with the expansion…
Arthralgia Treatment Market 2025 | Biologics, Gene Therapy & Digital Health Inno …
The Global Arthralgia Treatment Market is witnessing strong growth driven by factors such as the rising prevalence of joint pain and arthritis, an aging global population, and ongoing advancements in pain management therapies, including NSAIDs, corticosteroids, biologics, and personalized medicine approaches. Emerging opportunities in the arthralgia treatment market are rapidly evolving with the development of novel biologics and gene therapies that offer long-term and targeted symptom relief, significantly improving patient…
Global Arthralgia Treatment Market Overview, Trends & Competitive Strategies | 2 …
Global Arthralgia Treatment Market is expected to reach at a Significant CAGR during the forecast period 2024-2031.
The Arthralgia Treatment Market report, released by DataM Intelligence, offers comprehensive insights and thorough analysis of major market trends, growth prospects, and emerging challenges. With a strong focus on actionable intelligence, DataM Intelligence equips businesses with the knowledge needed to make strategic decisions and maintain a competitive advantage. Utilizing a blend of qualitative and…
Arthralgia Management Market Size, Share, Price, Trends, Growth, Analysis, Repor …
The global arthralgia management market share value was USD 6.55 billion in 2023, driven by the rising prevalence of autoimmune disorders, overuse injuries, and infectious diseases. The market size is anticipated to grow at a CAGR of 9.1% during the forecast period of 2024-2032 to achieve a value of USD 14.34 billion by 2032.
Arthralgia Management: Introduction
Arthralgia, or joint pain, is a common complaint among individuals of varying ages and can…
Arthralgia Treatment Market
Market Overview
The global Arthralgia Treatment Market is projected to experience a high Compound Annual Growth Rate (CAGR) during the forecast period from 2023 to 2030.
Understanding Arthralgia
Arthralgia, commonly known as joint pain, can affect various joints in the body, leading to discomfort and reduced mobility. It is associated with diverse conditions, including arthritis, bursitis, tendinitis, overuse injuries, gout, and other inflammatory disorders. Arthralgias may also result from the side effects of…
Arthralgia Drugs Market Size, Demand, and Future Outlook: Global Industry Trends …
This Arthralgia Drugs market report has been prepared by considering several fragments of the present and upcoming market scenario. The market insights gained through this market research analysis report facilitates more clear understanding of the market landscape, issues that may interrupt in the future, and ways to position definite brand excellently. It consists of most-detailed market segmentation, thorough analysis of major market players, trends in consumer and supply chain dynamics,…
